CDKN2A Polymorphism in Melanoma Patients in Colombian Population: A Case-Control Study

Table 3

Genotype and allele distributions of variants CDKN2A gene in cases and controls groups.

Genotype/allele	Cases (%)	Control (%)		value	OR (95% CI)
p.R24P
G/G	82 (96.47%)	162 (97.59%)	0.260	0.610	1.48 (0.32-6.77)
G/C	3 (3.53%)	4 (2.41%)
G	167	328	0.256	0.613	1.47 (0.32-6.65)
C	3	4
p.M53I
G/G	85 (100%)	166 (100%)	0.115	0.735	1,94 (0.03-99.00)
G/C	0	0
G	170	332	0.115	0.735	1.94 (0.03-98.57)
C	0	0
p.G101W
G/G	83 (97.65%)	166 (100%)	3.294	0.070	9.97 (0.47-210.05)
G/T	2 (2.35%)	0
G	168	332	3.280	0.070	9.85 (0.47-206.38)
T	2	0
p.V126D
T/T	83 (97.65%)	164 (98.80%)	0.473	0.492	1.97 (0.27-14.27)
T/A	2 (2.35%)	2 (1.20%)
A	2	2	0.469	0.494	1.96 (0.27-14.06)
T	168	330
p.A148T
G/G	80 (94.12%)	158 (95.18%)	0.129	0.719	1.23 (0.39-3.89)
G/A	5 (5.88%)	8 (4.82%)
G	165	324	0.126	0.723	1.22 (0.39-3.81)
A	5	8